Literature DB >> 24912050

Recent advances in head and neck squamous cell carcinoma--a review.

Yaghoub Safdari1, Masoumeh Khalili2, Safar Farajnia3, Mohammad Asgharzadeh4, Yaghoub Yazdani5, Mahnaz Sadeghi6.   

Abstract

The current review presents the results of the most recent studies performed on different aspects of human head and neck squamous cell carcinoma, including radiosensitivity induction, efficiency improvement of monoclonal antibodies using low-intensity ultrasound, chemical compounds such as toll-like receptor (TLC) agonists, dasatinib, resveratrol and niclosamide, nuclear inhibition of cancer using STAT3 decoy oligonucleotide, efficiency of anti-EGFR monoclonal antibodies in detection of head and neck cancers and other related issues.
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cetuximab; EGFR; Erlotinib; Head and neck cancer; Radiosensitivity

Mesh：

Substances：

Year:  2014        PMID： 24912050     DOI： 10.1016/j.clinbiochem.2014.05.066

Source DB:  PubMed          Journal:  Clin Biochem        ISSN： 0009-9120            Impact factor:   3.281


  14 in total

1.  Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.

Authors:  Chengfei Liu; Wei Lou; Cameron Armstrong; Yezi Zhu; Christopher P Evans; Allen C Gao
Journal:  Prostate       Date:  2015-05-13       Impact factor: 4.104

2.  Effect of human papillomavirus seropositivity and E2F2 promoter variants on risk of squamous cell carcinomas of oropharynx and oral cavity.

Authors:  Yuncheng Li; Erich M Sturgis; Ying Yuan; Meixia Lu; Xiaoli Cao; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2016-11-01       Impact factor: 4.944

Review 3.  Pathologic aspects of skull base tumors.

Authors:  Andrzej Marszałek; Łukasz Szylberg; Sławomir Wiśniewski
Journal:  Rep Pract Oncol Radiother       Date:  2016-04-03

4.  Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment.

Authors:  Talita Mendes Oliveira Ventura; Nathalia Regina Ribeiro; Even Akemi Taira; Aline de Lima Leite; Aline Dionizio; Cássia Maria Fischer Rubira; Paulo Sérgio da Silva Santos; Marília Afonso Rabelo Buzalaf
Journal:  Clin Oral Investig       Date:  2021-05-29       Impact factor: 3.573

5.  Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.

Authors:  Chang-Han Chen; Alice Y W Chang; Shau-Hsuan Li; Hsin-Ting Tsai; Li-Yen Shiu; Li-Jen Su; Wen-Lung Wang; Tai-Jen Chiu; Sheng-Dean Luo; Tai-Lin Huang; Chih-Yen Chien
Journal:  Mol Cancer       Date:  2015-04-12       Impact factor: 27.401

6.  HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.

Authors:  Runping Liu; Luyong Zhang; Jing Yang; Xiaoxuan Zhang; Ross Mikkelsen; Shiyu Song; Huiping Zhou
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 7.  Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer.

Authors:  Andrew T Baker; Andrei Zlobin; Clodia Osipo
Journal:  Front Oncol       Date:  2014-12-12       Impact factor: 6.244

8.  The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma.

Authors:  Bo Mi Ku; Seong Yoon Yi; Jiae Koh; Yeon-Hee Bae; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
Journal:  Oncotarget       Date:  2016-03-22

9.  Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.

Authors:  Xuan Zhou; Yu Ren; Lingping Kong; Guoshuai Cai; Shanshan Sun; Wangzhao Song; Yu Wang; Rui Jin; Lisha Qi; Mei Mei; Xudong Wang; Chunsheng Kang; Min Li; Lun Zhang
Journal:  Oncotarget       Date:  2015-10-20

10.  Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.

Authors:  Isolde Summerer; Julia Hess; Adriana Pitea; Kristian Unger; Ludwig Hieber; Martin Selmansberger; Kirsten Lauber; Horst Zitzelsberger
Journal:  BMC Genomics       Date:  2015-09-02       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.